Skip to main content

Qualigen Therapeutics, Inc. (QLGN)

NASDAQ: QLGN · IEX Real-Time Price · USD
1.24
-0.03 (-2.36%)
At close: Dec 8, 2021 4:00 PM
1.25
0.01 (0.81%)
After-hours:Dec 8, 2021 7:42 PM EST
Market Cap43.76M
Revenue (ttm)5.28M
Net Income (ttm)-4.69M
Shares Out35.29M
EPS (ttm)-0.34
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,733,545
Open1.27
Previous Close1.27
Day's Range1.16 - 1.27
52-Week Range0.93 - 4.66
Betan/a
AnalystsStrong Buy
Price Target7.75 (+525.0%)
Earnings DateNov 12, 2021

About QLGN

Qualigen, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-based infectious diseases; RAS-F3, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compound...

IndustryBiotechnology
Founded1996
CEOAndrew Ritter
Employees34
Stock ExchangeNASDAQ
Ticker SymbolQLGN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for QLGN stock is "Strong Buy" and the 12-month stock price forecast is 7.75.

Price Target
$7.75
(525.00% upside)
Analyst Consensus: Strong Buy

News

Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering

CARLSBAD, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announced the closing of its previously announced registered direct offering with certain institution...

1 week ago - GlobeNewsWire

Hot Biotech Penny Stocks to Buy Today? 3 For Your December Watchlist

Trading biotech penny stocks right now? Check these three out The post Hot Biotech Penny Stocks to Buy Today?

Other symbols:IBIOPTN
1 week ago - PennyStocks

QUALIGEN THERAPEUTICS, INC. ANNOUNCES $8.82 MILLION COMMON STOCK REGISTERED DIRECT OFFERING

CARLSBAD, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutic products for the treatment of cancer, as w...

1 week ago - GlobeNewsWire

Hot Penny Stocks to Add to Your Watchlist in December

If you're making a penny stocks watchlist for December, check these three out The post Hot Penny Stocks to Add to Your Watchlist in December appeared first on Penny Stocks to Buy, Picks, News and Inform...

Other symbols:ENICPTPI
1 week ago - PennyStocks

QLGN Stock Alert: 7 Things to Know as Qualigen Rockets Higher

Here's what investors may want to know about preclinical biotech firm Qualigen as QLGN stock absolutely skyrockets today. The post QLGN Stock Alert: 7 Things to Know as Qualigen Rockets Higher appeared ...

2 weeks ago - InvestorPlace

Best Penny Stocks to Buy Right Now? 3 to Watch Next Month

Why investors are watching these top penny stocks right now The post Best Penny Stocks to Buy Right Now? 3 to Watch Next Month appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS...

Other symbols:ABEVEDU
2 weeks ago - PennyStocks

Why Are Qualigen Therapeutics Shares Surging During Premarket Tuesday?

Qualigen Therapeutics Inc (NASDAQ:QLGN) shares are trading higher after a Zack's Small Cap research note showed a $9 price target on the stock. The report is based on a probability-adjusted DCF model th...

2 weeks ago - Benzinga

Hot Penny Stocks to Buy Right Now? 3 For Your Watchlist

Are these penny stocks on your watchlist right now? The post Hot Penny Stocks to Buy Right Now?

Other symbols:EXPRMARK
2 weeks ago - PennyStocks

Qualigen Therapeutics, Inc. Reports Third Quarter 2021 Financial Results

CARLSBAD, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutic products for the treatment of adult and pe...

3 weeks ago - GlobeNewsWire

Peer-Reviewed Article Confirms That Qualigen's FastPack® is as Accurate in Thyroid Stimulating Hormone Measurement --...

CARLSBAD, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential fo...

1 month ago - GlobeNewsWire

Qualigen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

CARLSBAD, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential f...

2 months ago - GlobeNewsWire

Qualigen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

CARLSBAD, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential f...

3 months ago - GlobeNewsWire

Why Qualigen Therapeutics (QLGN) Stock Plunging After Q2 Update

Tucked in its Q2 earnings release, Qualigen Therapeutics Inc (NASDAQ: QLGN) announced deprioritizing the QN-165 COVID-19 program, sending shares to fall to a 52-week low. In July, the Company filed an F...

3 months ago - Benzinga

Qualigen Files US Application To Start Human Trials For COVID-19 Candidate

Qualigen Therapeutics Inc (NASDAQ: QLGN) has submitted an Investigational New Drug (IND) application to the FDA for its QN-165 with an initial target indication of COVID-19 in hospitalized patients.  QN...

4 months ago - Benzinga

Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Tr...

CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral dis...

4 months ago - GlobeNewsWire

Qualigen Therapeutics Announces Inclusion in Russell Microcap® Index

CARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral dis...

6 months ago - GlobeNewsWire

Qualigen Therapeutics, Inc. to Present at the LD Micro Invitational XI Conference

CARLSBAD, Calif., June 02, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral dis...

6 months ago - GlobeNewsWire

Qualigen Therapeutics, Inc. Appoints Tariq Arshad, MD, MBA as Chief Medical Officer

New Position Created to Deepen Clinical Expertise and Advance Pipeline Therapeutic Programs

6 months ago - GlobeNewsWire

Qualigen Therapeutics, Inc. Reports First Quarter 2021 Financial Results and Provides Corporate Update

Conference call scheduled for May 18, 2021 at 4:10 p.m. EDT.

6 months ago - GlobeNewsWire

Qualigen Therapeutics Plans to Combat COVID-19 Variants

Qualigen Therapeutics Inc (NASDAQ: QLGN) was one of the sponsors for the Benzinga Biotech Global Small Cap Conference that took place on March 24-25, 2021. The information contained in this article in n...

7 months ago - Benzinga

Why Is Qualigen Stock Trading Lower Today?

Qualigen Therapeutics Inc (NASDAQ: QLGN) shares are ticking lower as the company withdrew the FDA Emergency Use Authorization (EUA) application for its FastPack SARS-CoV-2 IgG diagnostic test for COVID-...

7 months ago - Benzinga

Qualigen Therapeutics, Inc. Promotes Shishir Sinha to Chief Operating Officer Position

CARLSBAD, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectio...

8 months ago - GlobeNewsWire

Qualigen Therapeutics, Inc. to present at the Oppenheimer 31st Annual Healthcare Conference

CARLSBAD, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral di...

9 months ago - GlobeNewsWire

Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL

CARLSBAD, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral di...

9 months ago - GlobeNewsWire

Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering

CARLSBAD, Calif., Dec. 18, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announced the closing of its previously announced registered direct offering with a single institutional ...

11 months ago - PRNewsWire